Methods of treating progressive forms of multiple sclerosis comprising subcutaneously administering daclizumab

Multivalent fibronectin based scaffold domain proteins

Nucleic acids that encode interleukin-6 receptor binding polypeptides

Anti-c-Met antibodies

IL-17 binding proteins

Methods of treating autoimmune diseases by administering monoclonal antibodies against human IL-12

Neutralising antibodies to the major exotoxins TCDA and TCDB of

Anti-GITR antibodies

Modified polypeptides for bispecific antibody scaffolds

Binding molecules for BCMA and CD3

Anti-CD40 antibodies and methods of treating cancer

Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof

Methods and antibodies for treating cancer

Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptor

Methods and compositions to treat and detect misfolded-SOD1 mediated diseases

Immunoglobulins with reduced aggregation

IL-17 binding proteins

Anti-human CTGF antibody

Anti IL-6R polypeptides and compositions thereof

Nucleic acids encoding antibodies to CCR2

Anti-PD-L1 antibodies and uses thereof

Bispecific antibody fragments for neurological disease proteins and methods of use

Biological materials related to c-Met

Anti-folate receptor alpha antibodies and uses thereof

Humanized anti-human NKG2A monoclonal antibody

Antibodies against human CSF-1R and uses thereof

Nucleic acid assembly, vector, cell, methods and kit thereof

Immunogens comprising human immunodeficiency virus V1/V2 polypeptides

IN SILICO AFFINITY MATURATION

Method of isolating human antibodies

Anti-glucagon antibodies and uses thereof

PD-1 antibodies and PD-L1 antibodies and uses thereof

Anti-glucagon receptor antibodies and pharmaceutical compositions thereof

Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders

Methods of inhibiting plasma kallikrein in edema patient

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

Nucleic acids encoding IL-6R-binding polypeptides

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Apelin antigen-binding proteins and uses thereof

Anti-properdin antibodies

Affinity peptides toward infliximab

Anti-integrin β1 antibody compositions and methods of use thereof

Adrenomedullin assays and methods for determining mature adrenomedullin

Nucleic acids encoding antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Dual specific immunotoxin for brain tumor therapy

Anti-IL-6 receptor antibodies and methods of use

Methods of modulating adrenomedullin by administering an anti-adrenomedullin (ADM) antibody

Antibodies useful in passive influenza immunization

Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

Anti-B7-H4 antibodies and immunoconjugates

Nucleic acids encoding interleukin-31 monoclonal antibody and uses thereof

Anti-C5A binding moieties with high blocking activity

Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonist

Antibodies binding to IL-17A

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same

Endoglin antibodies

BMP-6 antibodies and DNA encoding the same

Sur-binding proteins against ERBB3

Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy

Antibodies directed against the alpha chain of IL7 receptor—their use for the preparation of drug candidates

Anti-ErbB3 antibodies and uses thereof

Class I anti-CEA antibodies and uses thereof

Antibodies that bind to TL1A and their uses

Targeted self-assembly of functionalized carbon nanotubes on tumors

Liquid formulation containing a protein drug

Anti-CD47 antibodies and methods of use thereof

Human antibodies specifically binding to the hepatitis B virus surface antigen

Anti-idiotype antibody against anti-c-MET antibody

Influenza virus antibody compositions

Methods of treating cancer by administering anti-GPR49 antibodies

Anti-GPR49 monoclonal antibodies

Method of treating hereditary angioedema using plasma kallikrein binding antibodies

Thrombin-binding antibody molecules

Anti-Axl antibodies and uses thereof

Combination therapy using anti-C-met antibody and anti-ang-2 antibody

ANTI-C-MET tandem Fc bispecific antibodies

Albumin binding antibodies and binding fragments thereof

Method of treating solid cancers using anti-c-Met antibody and sorafenib combination therapy

Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof

Antibodies against human IL33R and uses thereof

Antibody drug conjugates

Human anti-SOD1 antibodies

HLA-restricted, peptide-specific antigen binding proteins

Antibacterial polymers and method for obtaining the same

Site-specific antibody-drug conjugation through glycoengineering

Antagonistic DR3 ligands

Biological materials related to c-Met

Bispecific anti-Cmet/anti-Her2 antibodies

Fusion protein comprising anti-c-Met antibody and VEGF-binding fragment

Methods of treating a tauopathy

Fully human antibodies that bind to VEGFR2 and methods of use thereof

Humanized and affinity-matured anti-c-Met antibody and uses thereof

FC VARIANTS THAT IMPROVE FCRN BINDING AND/OR INCREASE ANTIBODY HALF-LIFE

Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof

Antibody and antibody mimetic for visualization and ablation of endogenous proteins

MET-binding agents and uses thereof

Antigen binding proteins

Animal models and therapeutic molecules

Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokinetics

Human monoclonal antibodies and methods for producing the same

Anti-human IL-23 receptor antibody

Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof

Human antibodies that bind human TNF-alpha and methods of preparing the same

Methods, compositions, and kits for detection of aspergillosis

HCV core lipid binding domain monoclonal antibodies

Antibody drug conjugates

Therapeutic uses for VEGFR1 antibodies

Therapeutic use of antibodies to HGF

Anti-IL-33 antibodies

Neutralizing anti-influenza A virus antibodies and uses thereof

Human antibodies to respiratory syncytial virus F protein and methods of use thereof

Anti-GP73 monoclonal antibodies and methods of obtaining the same

Interferon alpha and omega antibody antagonists

Pan-ELR+ CXC Chemokine Antibodies

Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)

Humanized, anti-N2 antibodies

Humanized anti-N2 antibodies and methods of treating ischemia-reperfusion injury

Anti-notch NRR antibodies and methods using same

Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)

Ion concentration-dependent binding molecule library

Antibodies that bind integrin alpha-V beta-8

Therapeutic use of antibodies to HGF

Antibodies to HGF and compositions containing

Dual specific binding proteins directed against IL-1 and/or IL-17

Immuno imaging agent for use with antibody-drug conjugate therapy

Velocity factor

Methods of blocking cancer stem cell growth

Method of treating stress hyperglycemia with human antibodies to the glucagon receptor

Diagnostic antibody assay

Methods for the treatment of IL-1β related diseases

Method of treating rheumatoid arthritis with an anti-IL-6R antibody

Immuno imaging agent for use with antibody-drug conjugate therapy

TDP-43 specific binding molecules

Anti-VCAM-1 nanobodies

Epitopes

Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity

Fusions of antibodies to CD38 and attenuated interferon alpha

High-throughput system and method for identifying antibodies having specific antigen binding activities

Bispecific T cell activating antigen binding molecules

Antibody variants and uses thereof

M-CSF specific monoclonal antibody and uses thereof

Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer

Alpha-synuclein antibodies and uses thereof

Antibodies to CD70

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

Peptide or arrangement of peptides forming a epitope binding site

HUMAN CTLA-4 ANTIBODIES AND THEIR USES

Antibodies against the ectodomain of ERBB3 and uses thereof

Human tissue factor antibody and uses thereof

Modified variable domain molecules and methods for producing them

Methods of treating a tauopathy

Chimeric and humanized anti-histone antibodies

Dual variable domain immunoglobulins and uses thereof

Serum albumin binding proteins

Prolactin receptor binding proteins and uses thereof

Anti-MCAM antibodies and associated methods of use

Method of treating pain with anti-human NGF antibody

Anti-pseudomonas Psl binding molecules and uses thereof

Anti-Axl antibodies and uses thereof

Combination therapy of anti-HER3 antibodies

Antibody-SN-38 immunoconjugates with a CL2A linker

Humanized anti-HLA-DR antibodies

Humanization of rabbit antibodies using a universal antibody framework

Interleukin-6 receptor binding polypeptides

Monovalent binding proteins

Anti-CD154 antibodies

Therapeutic use of specific ligand in MSRV associated diseases

IL-1 binding proteins

IL-11R binding proteins

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

ADAM6 mice

IL-1 binding proteins

Rapid clearance of antigen complexes using novel antibodies

Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer

Antibodies to IL-1 R1 and methods of making them

Human IL-23 antigen binding proteins

Anti-properdin antibodies and uses thereof

Toll-like receptor 3 antagonists

Anti-TNF-alpha antibodies and their uses

Anti-CEA antibodies

IL-1 binding proteins

Nucleic acid molecule encoding target antibodies directed to DLL4

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Anti-FOLR1 antibody

Anti c-Met antibodies

Optimized antibodies that target HM1.24

Antigen binding constructs

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

IL-1 binding proteins

Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses

Compositions and methods for antibodies targeting EPO

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

Heterodimerized polypeptide

Antibody drug conjugates (ADC) that bind to 161P2F10B proteins

Dual specificity antibody fusions

Monoclonal antibodies to fibroblast growth factor receptor 2

Anti-c-Met antibody having HGF activity and use thereof

Anti-GDF15 antibodies

Anti-human EPO receptor antibodies and methods of use

Bispecific anti-EGFR/anti IGF-1R antibodies

Antibodies binding to phosphorylcholine (PC) and/or PC conjugates

Antibodies specific to IL-17A and IL-17F

Anti-PDGFR-beta antibodies and uses thereof

Stable and soluble antibodies inhibiting TNF alpha

Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α

Monoclonal antibodies against Glypican-3

Polynucleotides encoding IL-31 monoclonal antibodies

Anti-interferon gamma antibodies and methods of use thereof

HER3 antibodies binding to the beta-hairpin of HER3

Anti-granulysin antibodies and methods of use thereof

Polynucleotides encoding anti-CD40 antibodies

Methods and compositions for targeting polyubiquitin

Inhibitors of type 2 vascular endothelial growth factor receptors

Methods for the generation of multispecific and multivalent antibodies

Nucleic acid encoding hepatocyte growth factor (HGF) binding proteins

Antibodies against phosphorylcholine

Anti-IL-23 antibodies

Amino acid sequence presenting fusion polypeptide and its use

IL-1 binding proteins

Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13

Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution

Antibody-like proteins for therapeutic and diagnostic use

Method for treating psoriasis by administering an anti-IL-12 antibody

Methods of generating libraries and uses thereof

Inhibition of bone resorption with RANKL binding peptides

Compositions and methods of use for antibodies of Dickkopf-1

Antibody recognizing N-domain of midkine

Compositions and methods for the treatment of neuromyelitis optica

Compositions and methods related to antibodies to staphylococcal protein A

Glypican-3-specific antibody and uses thereof

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Antibody specific for CD22 and methods of use thereof

BCMA antigen binding proteins

Bispecific antibodies directed against TNF-α and IL-17

Conjugated anti-CD38 antibodies

Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen

EGFR and C-Met fibronectin type III domain binding molecules

EGFR and c-Met fibronectin type III domain binding molecules

Heterodimeric immunoglobulins

Animal models and therapeutic molecules

EPHB3-specific antibody and uses thereof

HA binding agents

Antibodies to CD70

Polypeptides, antibody variable domains and antagonists

Method of treating type 1 diabetes with antagonist IL-7 receptor antibodies

Antibodies to CD70

Antibodies that inhibit metalloproteins

Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

Anti-complement C1s antibodies

Humanized L243 antibodies

Recombinant cell surface capture proteins

Human monoclonal antibodies to O8E

Platelet-derived growth factor B specific antibodies and compositions and uses thereof

Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof

Antibodies against prostate-specific stem cell antigen and use thereof

Antibodies for treatment of cancer

Anti-Notch3 antibodies and antibody-drug conjugates

Methods of inhibiting activation of complement component C4 with anti-C1s antibodies

Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

Anti-CD22 antibodies and immunoconjugates and methods of use

Anti-complement C1s

Antibodies recognizing alpha-synuclein

Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)

Antibodies against clostridium difficile toxins and uses thereof

Animal models and therapeutic molecules

Antibody specifically binding to insulin-like growth factor-1

Anti CEACAM1 antibodies and methods of using same

Treatment of tumors using specific anti-L1 antibody

Antibodies that are cross-reactive for macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (D-DT)

Antibodies to EphA3

Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses

Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A

Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders

Bispecific IgG antibodies as T cell engagers

Antibodies to insulin-like growth factor I receptor

Fc fusion proteins comprising novel linkers or arrangements

Meditopes and meditope-binding antibodies and uses thereof

Antibodies to interleukin-6

Anti-human HER3 antibodies and uses thereof

Methods for treating malaria by administering an antibody that specifically binds angiopoietin-2 (ang-2)

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

Anti-CD19 antibodies

Protein for affinity-separation matrix

Variant target binding agents and uses thereof

Frizzled-binding agents and uses thereof

Human C-FMS antibodies

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

Compositions relating to anti-IL-21 receptor antibodies

Anti-IL13 antibodies and uses thereof

Humanized anti-IL-18 antibodies

PTK7 modulators and methods of use

Anti-IL12Rβ1 antibodies and their use in treating autoimmune and inflammatory disorders

Nucleic acids encoding antibody polypeptides that antagonize CD40L

IL-1 binding proteins